Melissa A. Kelly Behrs

Corporate Officer/Principal bei GERON CORPORATION

59 Jahre

Health Technology

Consumer Services

Profil

Melissa A.
Kelly Behrs is currently the Chief Alliance Officer & EVP-Business Operations at Geron Corp.
She previously worked at Genetics Institute LLC as the Associate Director-Preclinical Operations.
Ms. Behrs holds an MBA from Babson College and an undergraduate degree from Boston College.

Aktive Positionen von Melissa A. Kelly Behrs

Unternehmen	Position	Beginn
GERON CORPORATION	Corporate Officer/Principal	01.11.1998

Alle aktiven Positionen von Melissa A. Kelly Behrs

Ehemalige bekannte Positionen von Melissa A. Kelly Behrs

Unternehmen	Position	Ende
Genetics Institute LLC Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01.01.1998

Sehen Sie sich die Erfahrung von Melissa A. Kelly Behrs im Detail an

Ausbildung von Melissa A. Kelly Behrs

Babson College	Masters Business Admin
Boston College	Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Melissa A. Kelly Behrs im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
GERON CORPORATION	Health Technology

Private Unternehmen	1
Genetics Institute LLC Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA.	Health Technology